RU2018147078A3 - - Google Patents

Download PDF

Info

Publication number
RU2018147078A3
RU2018147078A3 RU2018147078A RU2018147078A RU2018147078A3 RU 2018147078 A3 RU2018147078 A3 RU 2018147078A3 RU 2018147078 A RU2018147078 A RU 2018147078A RU 2018147078 A RU2018147078 A RU 2018147078A RU 2018147078 A3 RU2018147078 A3 RU 2018147078A3
Authority
RU
Russia
Application number
RU2018147078A
Other languages
Russian (ru)
Other versions
RU2018147078A (ru
RU2726210C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to RU2018147078A priority Critical patent/RU2726210C2/ru
Priority to KR1020217023854A priority patent/KR20210119408A/ko
Priority to CN201980093074.5A priority patent/CN113473994A/zh
Priority to PCT/RU2019/001031 priority patent/WO2020139163A2/ru
Priority to BR112021017961A priority patent/BR112021017961A2/pt
Publication of RU2018147078A publication Critical patent/RU2018147078A/ru
Publication of RU2018147078A3 publication Critical patent/RU2018147078A3/ru
Application granted granted Critical
Publication of RU2726210C2 publication Critical patent/RU2726210C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
RU2018147078A 2018-12-27 2018-12-27 Комбинация противовирусных средств, набор и способ лечения на ее основе RU2726210C2 (ru)

Priority Applications (5)

Application Number Priority Date Filing Date Title
RU2018147078A RU2726210C2 (ru) 2018-12-27 2018-12-27 Комбинация противовирусных средств, набор и способ лечения на ее основе
KR1020217023854A KR20210119408A (ko) 2018-12-27 2019-12-26 항바이러스제 복합물
CN201980093074.5A CN113473994A (zh) 2018-12-27 2019-12-26 抗病毒剂的组合、基于其治疗的试剂盒和方法
PCT/RU2019/001031 WO2020139163A2 (ru) 2018-12-27 2019-12-26 Комбинация противовирусных средств, набор и способ лечения на ее основе
BR112021017961A BR112021017961A2 (pt) 2018-12-27 2019-12-26 Combinação de agentes antivirais, kit e método de tratamento com base nos mesmos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018147078A RU2726210C2 (ru) 2018-12-27 2018-12-27 Комбинация противовирусных средств, набор и способ лечения на ее основе

Publications (3)

Publication Number Publication Date
RU2018147078A RU2018147078A (ru) 2020-06-29
RU2018147078A3 true RU2018147078A3 (zh) 2020-06-29
RU2726210C2 RU2726210C2 (ru) 2020-07-09

Family

ID=71130174

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018147078A RU2726210C2 (ru) 2018-12-27 2018-12-27 Комбинация противовирусных средств, набор и способ лечения на ее основе

Country Status (5)

Country Link
KR (1) KR20210119408A (zh)
CN (1) CN113473994A (zh)
BR (1) BR112021017961A2 (zh)
RU (1) RU2726210C2 (zh)
WO (1) WO2020139163A2 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA62910A1 (fr) * 2021-03-15 2023-12-29 Transposon Therapeutics Inc Inhibiteurs de line-1 pour traiter des maladies du snc et des maladies systémiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090053867A (ko) * 2003-01-14 2009-05-27 길리애드 사이언시즈, 인코포레이티드 복합 항바이러스 치료를 위한 조성물 및 방법
RU2331420C2 (ru) * 2005-12-08 2008-08-20 Роберт Шалвович Бибилашвили Противовирусное средство (варианты) и способ лечения на его основе
RU2446169C2 (ru) * 2010-05-28 2012-03-27 Закрытое акционерное общество "Производственно-коммерческая Ассоциация АЗТ" Способ получения 5'-аминокарбонилфосфонатов нуклеозидов и способ получения хлорангидрида триметилсилильного эфира этоксикарбонилфосфоновой кислоты
RU2441016C1 (ru) * 2010-05-28 2012-01-27 Закрытое акционерное общество "Производственно-коммерческая Ассоциация АЗТ" Соли 5'-аминокарбонилфосфоната 3'-азидо-3'-дезокситимидина, являющиеся селективными ингибиторами продукции вируса иммунодефицита человека вич-1
EP2714045A1 (en) * 2011-05-30 2014-04-09 Cipla Limited Pharmaceutical antiretroviral composition
CN104114570B (zh) * 2011-10-14 2016-08-31 齐多夫定生产和商业协会封闭式股份公司 作为人免疫缺陷病毒hiv-1产生的选择性抑制剂的氨基甲酰基膦酸酯盐
KR20150084772A (ko) * 2012-10-23 2015-07-22 시플라 리미티드 약학 항레트로바이러스 조성물

Also Published As

Publication number Publication date
RU2018147078A (ru) 2020-06-29
WO2020139163A2 (ru) 2020-07-02
CN113473994A (zh) 2021-10-01
KR20210119408A (ko) 2021-10-05
WO2020139163A3 (ru) 2020-08-27
BR112021017961A2 (pt) 2021-12-28
RU2726210C2 (ru) 2020-07-09

Similar Documents

Publication Publication Date Title
BR122022006221A2 (zh)
BR122022015534A2 (zh)
BR122022002075A2 (zh)
AT524834A2 (zh)
AT524874A5 (zh)
AU2018438767B1 (zh)
AT524266A2 (zh)
AT521543A3 (zh)
AT524961A5 (zh)
RU2018147078A3 (zh)
BR122022005529A2 (zh)
BR122022016585A2 (zh)
BR212020012832U2 (zh)
BR202018071071U8 (zh)
BE2018C025I2 (zh)
BR202018008879U2 (zh)
BR202018007669U2 (zh)
BR102018007062A2 (zh)
BR202018006247U2 (zh)
BR202018004136U2 (zh)
BR202018002487U2 (zh)
BR202018002069U2 (zh)
CN304439671S (zh)
CN304434432S (zh)
CN304434276S (zh)